Abstract
Blood vessels serve as the lifeline of nearly all living tissue. Vascular cells derived from human pluripotent stem cells hold great potential for clinical use in the regeneration of diseased vasculature and construction of blood vessels in engineered tissue. By deriving these cells in a controllable and clinically relevant manner harnessing physiological cues, we can obtain populations of cells amenable for transplantation. In this chapter, we describe methods to differentiate human pluripotent stem cells toward a bicellular population of early vascular cells using low oxygen cues, guide these subpopulations into mature endothelial cells and pericytes, and expand the vascular derivatives.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Discher DE, Mooney DJ, Zandstra PW (2009) Growth factors, matrices, and forces combine and control stem cells. Science 324(5935):1673–1677
Kusuma S, Gerecht S (2010) Engineering blood vessels using stem cells: innovative approaches to treat vascular disorders. Expert Rev Cardiovasc Ther 8(10):1433–1445
Kusuma S, Gerecht S (2013) Recent progress in the use of induced pluripotent stem cells in vascular regeneration. Expert Rev Cardiovasc Ther 11(6):661–663
James D et al (2010) Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGF inhibition is Id1 dependent. Nat Biotechnol 28(2):161–166
Kusuma S, Facklam A, Gerecht S (2014) Characterizing human pluripotent stem cell-derived vascular cells for tissue engineering applications. Stem Cells Dev, Sept 18 (Epub ahead of print). doi: 10.1089/scd.2014.0377
Crisan M, Corselli M, Chen WC, Péault B (2012) Perivascular cells for regenerative medicine. J Cell Mol Med 16(12):2851–2860
Birukov KG, Stepanova OV, Nanaev AK, Shirinsky VP (1991) Expression of calponin in rabbit and human aortic smooth muscle cells. Cell Tissue Res 266(3):579–584
Dar A et al (2012) Multipotent vasculogenic pericytes from human pluripotent stem cells promote recovery of murine ischemic limb (translated from Eng). Circulation 125(1):87–99 (in Eng)
Prado-Lopez S et al (2010) Hypoxia promotes efficient differentiation of human embryonic stem cells to functional endothelium. Stem Cells 28(3):407–418
Shin JM et al (2011) Enhancement of differentiation efficiency of hESCs into vascular lineage cells in hypoxia via a paracrine mechanism. Stem Cell Res 7(3):173–185
Han Y, Kuang SZ, Gomer A, Ramirez-Bergeron DL (2010) Hypoxia influences the vascular expansion and differentiation of embryonic stem cell cultures through the temporal expression of vascular endothelial growth factor receptors in an ARNT-dependent manner. Stem Cells 28(4):799–809
Kusuma S, Peijnenburg E, Patel P, Gerecht S (2014) Low oxygen tension enhances endothelial fate of human pluripotent stem cells. Arterioscler Thromb Vasc Biol 34(4):913–920
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Kusuma, S., Gerecht, S. (2014). Derivation of Endothelial Cells and Pericytes from Human Pluripotent Stem Cells. In: Turksen, K. (eds) Human Embryonic Stem Cell Protocols. Methods in Molecular Biology, vol 1307. Humana Press, New York, NY. https://doi.org/10.1007/7651_2014_149
Download citation
DOI: https://doi.org/10.1007/7651_2014_149
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2667-1
Online ISBN: 978-1-4939-2668-8
eBook Packages: Springer Protocols